Atualização Científica >> Destaques de Revistas

Optimal pharmacologic approach to patients with hypertriglyceridemia and low high-density lipoprotein-cholesterol: randomized comparison of fenofibrate 160 mg and niacin 1500 mg.

Wi J, Kim JY, Park S, Kang SM, Jang Y, Chung N, et al. Atherosclerosis. 2010 Nov;213(1):235-40.

Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Atherosclerosis. 2010 Nov;213(1):299-305.

Coronary artery calcification progression and cardiovascular events in renal transplant recipients, bad inheritance from previous kidney disease: Commentary on the study of Roe et al.

Santos RD.Atherosclerosis. 2010 Oct;212(2):390-1.

Inflammation, coronary artery calcification and cardiovascular events in incident renal transplant recipients.

Roe P, Wolfe M, Joffe M, Rosas SE. Atherosclerosis. 2010 Oct;212(2):589-94.

Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: Clinical evidence and pathophysiological mechanisms.

Lang CC, Gupta S, Kalra P, Keavney B, Menown I, Morley C, Padmanabhan S. Atherosclerosis. 2010 Sep;212(1):1-8.

Exercise training accelerates the removal from plasma of LDL-like nanoemulsion in moderately hypercholesterolemic subjects.

Ficker ES, Maranhão RC, Chacra AP, Neves VC, Negrão CE, Martins VC, Vinagre CG. Atherosclerosis. 2010 Sep;212(1):230-6.

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors.

Subclinical peripheral arterial disease in rheumatoid arthritis.

Stamatelopoulos KS, Kitas GD, Papamichael CM, Kyrkou K, Zampeli E, Fragiadaki K, et al. Atherosclerosis. 2010 Sep;212(1):305-9

Impact of coronary calcium on arterial age and coronary heart disease risk estimation using the MESA arterial age calculator.

Munir JA, Wu H, Bauer K, Bindeman J, Byrd C, O'Malley P, Taylor AJ. Atherosclerosis. 2010 Aug;211(2):467-70.

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study.

Neil HA, Cooper J, Betteridge DJ, Capps N, McDowell IF, Durrington PN, et al; Simon Broome Familial Hyperlipidaemia Register Group. Atherosclerosis. 2010 Aug;211(2):618-23.

Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis

van Leuven SI, van Wijk DF, Volger OL, de Vries JP, van der Loos CM, de Kleijn DV, et al. Atherosclerosis. 2010 Jul;211(1):231-6

Serial decline of kidney function as a novel biomarker for the progression of atherothrombotic disease.

Rein P, Saely CH, Muendlein A, Vonbank A, Drexel H. Atherosclerosis. 2010 Jul;211(1):348-52.

Lipid transfer proteins: past, present and perspectives.

Quintão EC, Cazita PM. Atherosclerosis. 2010 Mar;209(1):1-9

Desenvolvido pela Diretoria de Tecnologia da SBC
Todos os Direitos Reservados © Copyright 2015
Sociedade Brasileira de Cardiologia | Tecnologia@cardiol.br